VIDEO: Promising data for bimekizumab in psoriasis treatment

In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the recently approved interleukin-17 inhibitor bimekizumab from the Maui Derm 2024 meeting, examining its use in treating psoriasis.

Chovatiya, assistant professor of dermatology at Northwestern University Feinberg School of Medicine, discussed long-term data into bimekizumab, which showed good efficacy and safety data.

“I would sort of say the majority of people actually achieved almost complete, if not complete clearance of the scalp and palmoplantar areas by the end of the treatment period,” Chovatiya said.